Lipidomics
[Closed for Investment] Lipidomics, Inc. is here with the solution for inflammatory skin diseases. They develop cosmetics and pharmaceutical products for dry and sensitive skin that help replenish liquids that are deficient in the skin barrier. Lipidomics scientific founders have been studying fundamental skin biology and dermatology for over two decades, and their studies have led them to create a topical application of two specific lipids that are effective for treating dry skin that can often be a precursor to eczema. Current treatments can suppress the immune response or have detrimental effects on skin health. Lipidomics’ product helps prevent that, allowing the integrity of the skin barrier to remain intact without triggering an immune response.
Investment Overview
Raised: $2,095
Deal Terms
Company & Team
Company
- Year Founded
- 2016
- Industry
- Healthcare & Pharmaceuticals
- Tech Sector
- Location
- Corvallis, Oregon
- Company Website
-
Visit Website
Team
- Employees
- 4
Financials
Upgrade to gain access
-
$12.50 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific Kingscrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Company Funding & Growth
Funding history
Close Date | Platform | Valuation | Total Raised | Security Type | Status | Reg Type |
---|---|---|---|---|---|---|
10/01/2018 | Netcapital | $2,801,443 | $2,095 | Equity - Common | Not Funded | RegCF |